Marinus Pharmaceuticals: Q3 Earnings Snapshot

Audio By Carbonatix

RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Tuesday reported a loss of $19.5 million in its third quarter.

On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 53 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The epilepsy drug developer posted revenue of $10.1 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $2.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS